Emergency Department Management of COVID-19: An Evidence-Based Approach
Open Access
- 25 September 2020
- journal article
- research article
- Published by Western Journal of Emergency Medicine in Western Journal of Emergency Medicine
- Vol. 21 (6) , 32-44
Abstract
The novel coronavirus, SARs-CoV-2, causes a clinical disease known as COVID-19. Since being declared a global pandemic, a significant amount of literature has been produced and guidelines are rapidly changing as more light is shed on this subject. Decisions regarding disposition must be made with attention to comorbidities. Multiple comorbidities portend a worse prognosis. Many clinical decision tools have been postulated; however, as of now, none have been validated. Laboratory testing available to the emergency physician is nonspecific but does show promise in helping prognosticate and risk stratify. Radiographic testing can also aid in the process. Escalating oxygen therapy seems to be a safe and effective therapy; delaying intubation for only the most severe cases in which respiratory muscle fatigue or mental status demands this. Despite thrombotic concerns in COVID-19, the benefit of anticoagulation in the emergency department (ED) seems to be minimal. Data regarding adjunctive therapies such as steroids and nonsteroidal anti-inflammatories are variable with no concrete recommendations, although steroids may decrease mortality in those patients developing acute respiratory distress syndrome. With current guidelines in mind, we propose a succinct flow sheet for both the escalation of oxygen therapy as well as ED management and disposition of these patients.Keywords
This publication has 122 references indexed in Scilit:
- High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory FailureNew England Journal of Medicine, 2015
- Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus InfectionAnnals of Internal Medicine, 2014
- Vasopressors for hypotensive shock2011
- Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patientsJournal of Clinical Virology, 2004
- Inhalation of Nitric Oxide in the Treatment of Severe Acute Respiratory Syndrome: A Rescue Trial in BeijingClinical Infectious Diseases, 2004
- Factors Associated with Psychosis among Patients with Severe Acute Respiratory Syndrome: A Case-Control StudyClinical Infectious Diseases, 2004
- Severe acute respiratory syndrome: report of treatment and outcome after a major outbreakThorax, 2004
- Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress SyndromeJAMA, 1998
- High-Dose Corticosteroids in Patients with the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1987
- Early Steroid Therapy for Respiratory FailureArchives of Surgery, 1985